Literature DB >> 11292714

Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.

M Kuboniwa1, A Amano, S Shizukuishi, I Nakagawa, S Hamada.   

Abstract

Lys-gingipain (KGP), a lysine-specific cysteine proteinase, is one of the major virulence factors of Porphyromonas gingivalis. Here we examined the involvement of the catalytic domain of KGP (KGP(cd)) in hemoglobin binding by P. gingivalis, using a specific immunoglobulin G (IgG) elicited by the administration of plasmid DNA encoding KGP(cd) or the catalytic domain of Arg-gingipain (RGP(cd)). The pSeq2A/kgp(cd) and pSeq2B/rgp(cd) plasmids were constructed by the ligation of kgp(cd) and rgp(cd) DNA fragments, respectively. Female BALB/c mice were immunized with each of these plasmids. pSeq2A/kgp(cd) elicited a strong response to recombinant KGP(cd) (rKGP(cd)), as well as to comparably produced rRGP(cd)-reactive antibodies. The serum antibodies elicited by pSecTag2B/rgp(cd) also cross-reacted with rKGP(cd) as well as rRGP(cd). Anti-KGP(cd) IgG significantly inhibited hemoglobin binding by P. gingivalis. Furthermore, the inhibition of hemoglobin binding was markedly enhanced by a combination of anti-KGP(cd) and anti-fimbriae. Anti-RGP(cd) IgG showed a negligible inhibitory effect, while both anti-KGP(cd) and anti-RGP(cd) IgGs showed significant inhibitory effects on Lys- and Arg-specific proteolytic activities and on the growth of P. gingivalis under iron-restricted conditions where supplemented hemoglobin was the sole iron source. Immunized mice were challenged by intraperitoneal inoculation with P. gingivalis. All nonimmunized mice died within 72 h; however, vaccination with pSeq2A/kgp(cd) and pSeq2B/rgp(cd) prevented inflammatory responses and prolonged the survival rate of immunized mice by 43 and 27%, respectively. These results suggest that KGP(cd) acts as a hemoglobin-binding protein and can also be useful as an immunogen inducing a protective response to P. gingivalis infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292714      PMCID: PMC98250          DOI: 10.1128/IAI.69.5.2972-2979.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Involvement of a lysine-specific cysteine proteinase in hemoglobin adsorption and heme accumulation by Porphyromonas gingivalis.

Authors:  K Okamoto; K Nakayama; T Kadowaki; N Abe; D B Ratnayake; K Yamamoto
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

Review 2.  DNA vaccines.

Authors:  H L Robinson; C A Torres
Journal:  Semin Immunol       Date:  1997-10       Impact factor: 11.130

3.  Role of Arg-gingipain A in virulence of Porphyromonas gingivalis.

Authors:  M Tokuda; T Karunakaran; M Duncan; N Hamada; H Kuramitsu
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Longitudinal study of prognostic factors in established periodontitis patients.

Authors:  E E Machtei; R Dunford; E Hausmann; S G Grossi; J Powell; D Cummins; J J Zambon; R J Genco
Journal:  J Clin Periodontol       Date:  1997-02       Impact factor: 8.728

5.  Biochemical and functional properties of lysine-specific cysteine proteinase (Lys-gingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease.

Authors:  N Abe; T Kadowaki; K Okamoto; K Nakayama; M Ohishi; K Yamamoto
Journal:  J Biochem       Date:  1998-02       Impact factor: 3.387

6.  A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.

Authors:  C A Genco; B M Odusanya; J Potempa; J Mikolajczyk-Pawlinska; J Travis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Hemoglobin-binding protein purified from Porphyromonas gingivalis is identical to lysine-specific cysteine proteinase (Lys-gingipain).

Authors:  M Kuboniwa; A Amano; S Shizukuishi
Journal:  Biochem Biophys Res Commun       Date:  1998-08-10       Impact factor: 3.575

Review 8.  Proteases of Porphyromonas gingivalis: what don't they do?

Authors:  H K Kuramitsu
Journal:  Oral Microbiol Immunol       Date:  1998-10

9.  Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis.

Authors:  T Kadowaki; K Nakayama; F Yoshimura; K Okamoto; N Abe; K Yamamoto
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

Review 10.  Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis.

Authors:  R J Lamont; H F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more
  18 in total

1.  Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct types of Porphyromonas gingivalis fimbriae.

Authors:  Ichiro Nakagawa; Hiroaki Inaba; Taihei Yamamura; Takahiro Kato; Shinji Kawai; Takashi Ooshima; Atsuo Amano
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Investigation of arginine A-specific cysteine proteinase gene expression profiling in clinical Porphyromonas gingivalis isolates against photokilling action of the photo-activated disinfection.

Authors:  Maryam Pourhajibagher; Roghayeh Ghorbanzadeh; Abbas Bahador
Journal:  Lasers Med Sci       Date:  2017-11-15       Impact factor: 3.161

3.  Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.

Authors:  Maximilian F Konig; Alizay S Paracha; Malini Moni; Clifton O Bingham; Felipe Andrade
Journal:  Ann Rheum Dis       Date:  2014-05-26       Impact factor: 19.103

4.  DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.

Authors:  Xiaozhe Han; Karen B LaRosa; Toshihisa Kawai; Martin A Taubman
Journal:  Vaccine       Date:  2013-09-16       Impact factor: 3.641

5.  Functional differences among FimA variants of Porphyromonas gingivalis and their effects on adhesion to and invasion of human epithelial cells.

Authors:  Ichiro Nakagawa; Atsuo Amano; Masae Kuboniwa; Takayuki Nakamura; Shigetada Kawabata; Shigeyuki Hamada
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats.

Authors:  Brian Bainbridge; Raj K Verma; Christie Eastman; Bilal Yehia; Mercedes Rivera; Catherine Moffatt; Indraneel Bhattacharyya; Richard J Lamont; Lakshmyya Kesavalu
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

7.  HGP44 induces protection against Porphyromonas gingivalis-Induced alveolar bone loss in mice.

Authors:  Kyotaro Muramatsu; Eitoyo Kokubu; Takahiko Shibahara; Katsuji Okuda; Kazuyuki Ishihara
Journal:  Clin Vaccine Immunol       Date:  2011-03-23

8.  Gingipain RgpB is excreted as a proenzyme in the vimA-defective mutant Porphyromonas gingivalis FLL92.

Authors:  G Jon Olango; Francis Roy; Shaun M Sheets; Mary K Young; Hansel M Fletcher
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes.

Authors:  Benfang Lei; Laura M Smoot; Heather M Menning; Jovanka M Voyich; Subbarao V Kala; Frank R Deleo; Sean D Reid; James M Musser
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase.

Authors:  Martin A Taubman; Xiaozhe Han; Karen B Larosa; Sigmund S Socransky; Daniel J Smith
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.